Related references
Note: Only part of the references are listed.Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus A Scientific Statement From the American Heart Association
Suzanne Arnold et al.
CIRCULATION (2020)
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease Insights From the COMPASS Trial
Deepak L. Bhatt et al.
CIRCULATION (2020)
Rivaroxaban in Peripheral Artery Disease after Revascularization
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Heart Failure With Reduced Ejection Fraction A Review
Sean P. Murphy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
Thomas A. Zelniker et al.
CIRCULATION (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
Deepak L. Bhatt et al.
LANCET (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Kausik K. Ray et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
P. Gabriel Steg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial
Julio Rosenstock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker et al.
LANCET (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrumof heart failure risk in the EMPA-REG OUTCOME® trial
David Fitchett et al.
EUROPEAN HEART JOURNAL (2018)
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin - (CARMELINA (R)): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk
Julio Rosenstock et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus
David A. McAllister et al.
CIRCULATION (2018)
Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
Julio A. Lamprea-Montealegre et al.
DIABETES CARE (2018)
Economic Costs of Diabetes in the US in 2017
Wenya Yang et al.
DIABETES CARE (2018)
Heart failure with preserved ejection fraction: from mechanisms to therapies
Carolyn S. P. Lam et al.
EUROPEAN HEART JOURNAL (2018)
Characteristics of patients prescribed Evolocumab in Europe. Does clinical use match clinical guidelines?
K. Ray et al.
EUROPEAN HEART JOURNAL (2018)
Hypertensive Disorders of Pregnancy ISSHP Classification, Diagnosis, and Management Recommendations for International Practice
Mark A. Brown et al.
HYPERTENSION (2018)
Individualizing Blood Pressure Targets for People With Diabetes and Hypertension Comparing the ADA and the ACC/AHA Recommendations
Ian H. de Boer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension
Robert A. Phillips et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial
Kaycee M. Sink et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Peter M. Bothwell et al.
LANCET (2018)
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Stuart J. Connolly et al.
LANCET (2018)
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
R. Estruch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials
Srinivasan Beddhu et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Robert P. Giugliano et al.
CIRCULATION (2018)
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka A Randomized Clinical Trial
Ruth Webster et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
J. Michael Gaziano et al.
LANCET (2018)
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
J. J. McNeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Sandeep R. Das et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez et al.
LANCET (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
Francois Mach et al.
EUROPEAN HEART JOURNAL (2018)
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum
William T. Cefalu et al.
DIABETES CARE (2018)
Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials
Tom F. Brouwer et al.
DIABETES CARE (2018)
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
Erik Nilsson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10-Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials
Costas Thomopoulos et al.
JOURNAL OF HYPERTENSION (2017)
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
Erin A. Bohula et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Cognitive Function in a Randomized Trial of Evolocumab
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials
Sanjay Basu et al.
PLOS MEDICINE (2017)
Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
Ghassan Bandak et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Marc S. Sabatine et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis
Shaista Malik et al.
JAMA CARDIOLOGY (2017)
Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP
Leo F. Buckley et al.
DIABETES CARE (2017)
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Ian H. de Boer et al.
DIABETES CARE (2017)
The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals
Jan M. Hughes-Austin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial
Bruce Neal et al.
DIABETES OBESITY & METABOLISM (2017)
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes
Francesco Zaccardi et al.
DIABETES (2016)
Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes
M. A. Bethel et al.
DIABETIC MEDICINE (2016)
Value of Coronary Computed Tomography Angiography in Tailoring Aspirin Therapy for Primary Prevention of Atherosclerotic Events in Patients at High Risk With Diabetes Mellitus
Aukelien C. Dimitriu-Leen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction
Erin A. Bohula et al.
CIRCULATION (2016)
The Implications of Blood Pressure Measurement Methods on Treatment Targets for Blood Pressure
George L. Bakris
CIRCULATION (2016)
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
Gerasimos Filippatos et al.
EUROPEAN HEART JOURNAL (2016)
Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease Shared Decision Making in Clinical Practice
Samia Mora et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
Xinfang Xie et al.
LANCET (2016)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET (2016)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses
Mattias Brunstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses
Ferran Catala-Lopez et al.
PLOS MEDICINE (2016)
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses
Mattias Brunstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
Matthew T. James et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Xin-Lin Zhang et al.
BMC MEDICINE (2015)
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Matthew A. Cavender et al.
CIRCULATION (2015)
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)
Nikolaus Marx et al.
DIABETES & VASCULAR DISEASE RESEARCH (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Lowering blood pressure in diabetes
Seema Kang
LANCET DIABETES & ENDOCRINOLOGY (2015)
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
Faiez Zannad et al.
LANCET (2015)
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
Suetonia C. Palmer et al.
LANCET (2015)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams et al.
LANCET (2015)
Less-Tight versus Tight Control of Hypertension in Pregnancy
Laura A. Magee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
Sanne Bojet Larsen et al.
PLOS ONE (2015)
Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis
Rachel R. Huxley et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Renal denervation for the treatment of resistant hypertension: review and clinical perspective
Radu Iliescu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis
Connor A. Emdin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Type 1 Diabetes Mellitus and Cardiovascular Disease A Scientific Statement From the American Heart Association and American Diabetes Association
Sarah D. de Ferranti et al.
CIRCULATION (2014)
Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis
Michael D. Miedema et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Sex Differences in Diabetes and Risk of Incident Coronary Artery Disease in Healthy Young and Middle-Aged Adults
Rita Rastogi Kalyani et al.
DIABETES CARE (2014)
Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
Karen L. Margolis et al.
DIABETES CARE (2014)
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events
Sanne A. E. Peters et al.
DIABETOLOGIA (2014)
Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations
Paul Muntner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Patrick M. Moriarty et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Michael D. Jensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
LANCET (2014)
Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes
Sanne A. E. Peters et al.
LANCET (2014)
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
S. Zoungas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
Martin J. Landray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Statins and Cognitive Function
Karl Richardson et al.
ANNALS OF INTERNAL MEDICINE (2013)
Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies
Stefano Omboni et al.
JOURNAL OF HYPERTENSION (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Achievement of Goals in U.S. Diabetes Care, 1999-2010
Mohammed K. Ali et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
Rena Wing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Risk of incident diabetes among patients treated with statins: population based study
Aleesa A. Carter et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
Harikrishna Makani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
Andrew S. Bomback et al.
BLOOD PURIFICATION (2012)
Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (vol 141, pg e637S, 2012)
Per Olav Vandvik
CHEST (2012)
Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study
Claire Meek et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Lars Berglund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
Stephan D. Fihn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Paul M. Ridker et al.
LANCET (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it Ok to Discontinue?
Anna Kezerashvili et al.
CURRENT CARDIOLOGY REVIEWS (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
Primary and Secondary Prevention of Cardiovascular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Olav Vandvik et al.
CHEST (2012)
Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials
Sripal Bangalore et al.
CIRCULATION (2011)
Influence of Time of Day of Blood Pressure-Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes
Ramon C. Hermida et al.
DIABETES CARE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prognostic Value of Coronary Computed Tomographic Angiography in Diabetic Patients Without Known Coronary Artery Disease
Martin Hadamitzky et al.
DIABETES CARE (2010)
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
Chunyu Zhang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Pravastatin and cognitive function in the elderly. Results of the PROSPER study
Stella Trompet et al.
JOURNAL OF NEUROLOGY (2010)
Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
Michael A. Weber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
William C. Cushman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Assessment of Subclinical Coronary Atherosclerosis in Asymptomatic Patients With Type 2 Diabetes Mellitus With Single Photon Emission Computed Tomography and Coronary Computed Tomography Angiography
Eue-Keun Choi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Swapnil N. Rajpathak et al.
DIABETES CARE (2009)
Simplified Approach to the Treatment of Uncomplicated Hypertension A Cluster Randomized, Controlled Trial
Ross D. Feldman et al.
HYPERTENSION (2009)
Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes The DIAD Study: A Randomized Controlled Trial
Lawrence H. Young et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
Giorgia De Berardis et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study
Robert S. Elkeles et al.
EUROPEAN HEART JOURNAL (2008)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S. Yusuf et al.
LANCET (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
Jill Belch et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Mechanisms of disease:: Platelet activation and atherothrombosis
Giovanni Davi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the detection of ischemia in asymptomatic diabetics (DIAD) study
Frans J. Th. Wackers et al.
DIABETES CARE (2007)
Screening for coronary artery disease in patients with diabetes
Jeroen J. Bax et al.
DIABETES CARE (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis
Sonal Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
A. Patel et al.
LANCET (2007)
High-density lipoprotein as a therapeutic target - A systematic review
Inder M. Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Fixed-dose combinations improve medication compliance: A meta-analysis
Sripal Bangalore et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Aspirin dose for the prevention of cardiovascular disease - A systematic review
Charles L. Campbell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Optimal medical therapy with or without PCI for stable coronary disease
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association
John B. Buse et al.
DIABETES CARE (2007)
Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
Robert H. Knopp et al.
DIABETES CARE (2006)
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes - The treating to new targets (TNT) study
James Shepherd et al.
DIABETES CARE (2006)
Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: A cost-utility analysis
M Pignone et al.
ANNALS OF INTERNAL MEDICINE (2006)
Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy
DV Anand et al.
EUROPEAN HEART JOURNAL (2006)
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus
R Scognamiglio et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure
DT Eurich et al.
DIABETES CARE (2005)
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes:: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)
PS Sever et al.
DIABETES CARE (2005)
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population - Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study
R Sega et al.
CIRCULATION (2005)
Reporting rate of Rhabdomyolysis with fenofibrate plus statin versus gemfibrozil plus any statin
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study
FJT Wackers et al.
DIABETES CARE (2004)
Atenolol in hypertension: is it a wise choice?
B Carlberg et al.
LANCET (2004)
Pharmacogenetic study of statin therapy and cholesterol reduction
DI Chasman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Prognostic value of coronary artery calcium screening in subjects with and without diabetes
P Raggi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Long term mortality of mothers and fathers after pre-eclampsia:: population based cohort study
HU Irgens et al.
BRITISH MEDICAL JOURNAL (2001)
Is isolated home hypertension as opposed to isolated office hypertension a sign of greater cardiovascular risk?
G Bobrie et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet.
FM Sacks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
